Bruker’s EVOQ® DART-TQ+ could be a game-changer for us. Cycle time reductions from 6 and 7 minutes to less than 30 seconds and direct costs at about 30% of our standard LC-MS/MS.
We are seeing the sensitivity needed to identify these new synthetic drugs, too. Faster, cheaper, and sensitive enough for what we need. Like I said, these Bruker DARTs could be game-changers.
R. Scott LaNeve
General Manager, Drugscan, Inc.
The reliable EVOQ® DART-TQ+ system enables straightforward routine assay workflows from simplified tuning and method development through data analysis and report generation for improved lab efficiency and productivity.
Using the fully integrated DART ionization source, chromatography-free workflows using PinPoint Testing’s ToxBox® panels can be easily implemented making the EVOQ® DART-TQ+ MS even more productive and economical to operate.
The EVOQ® DART-TQ+ streamlines instrument operation and offers robust data processing, significantly improving the throughput and operating costs of routine analytical screening in laboratories as compared to immunoassay and chromatography-based measurements.
Recent work demonstrates the quantitative strength of DART-MS in toxicology, forensics, and therapeutic drug monitoring - with data well correlated to traditional LC-MS-based measurements using simple extraction protocols from complex matrices like urine, whole blood, plasma, serum, and oral fluids. Bruker and its collaborators have developed numerous workflows that achieve quantification in as little as 15 seconds per sample, thereby significantly enhancing throughput and efficiency in analytical labs.
Download here our Applications Catalog Forensics & Toxicology:
For Research Use Only. Not for use in clinical diagnostic procedures.